Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Stephanie Rondeau"'
Autor:
Simona Berardi Vilei, Andreas Lohri, Mario Bargetzi, Ulrich Mey, Micaela Hernberg, Stefan Dirnhofer, Thilo Zander, Ann-Sofie Johansson, Peter de Nully Brown, Walter Mingrone, Eva Kimby, Bjørn Østenstad, Urban Novak, Daniel Rauch, Björn E. Wahlin, Fatime Krasniqi, Felicitas Hitz, Emanuele Zucca, Michele Ghielmini, Stefanie Hayoz, Hans Hagberg, Hanne Skjerven Bersvendsen, Hanne Hawle, Andrés J.M. Ferreri, Anna Vanazzi, Stephanie Rondeau
Publikováno v:
Blood. 134:353-362
The SAKK 35/10 phase 2 trial, developed by the Swiss Group for Clinical Cancer Research and the Nordic Lymphoma Group, compared the activity of rituximab vs rituximab plus lenalidomide in untreated follicular lymphoma patients in need of systemic the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0fd9e89e0f0247df56153468353844f
https://doi.org/10.1182/blood-2018-10-879643
https://doi.org/10.1182/blood-2018-10-879643
Autor:
Christoph Driessen, Andrej Besse, Panagiotis Samaras, Daniel Betticher, Ulrich Mey, Rouven Müller, Nathan Cantoni, Thilo Zander, Catherine Berset, Thomas Pabst, Stephanie Rondeau, Lenka Besse, Karin Ribi, Urban Novak, Hanne Hawle, Nicolas Mach, Felicitas Hitz, Axel Rüfer
Publikováno v:
Blood, Vol. 132, No 19 (2018) pp. 2097-2100
TO THE EDITOR: Treatment of proteasome inhibitor (PI)–refractory multiple myeloma (MM) is challenging, with response rates of only 15% to 35% being achieved with next-generation drugs such as pomalidomide, carfilzomib, and daratumumab, alone or in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ec1be89591b0a1408e3c10c9189b94
https://doi.org/10.1182/blood-2018-05-851170
https://doi.org/10.1182/blood-2018-05-851170
Autor:
Erika Lerch, Michele Ghielmini, Jochen Rentschler, Thomas Pabst, Lorenz M. Jost, Stephanie Rondeau, Simona Berardi Vilei, Mario Bargetzi, Luciano Wannesson, Angelika Bischof Delaloye, Michèle Voegeli, Nicolas Ketterer
Publikováno v:
Hematological Oncology. 35:576-583
Standard conditioning regimens for autologous stem cell transplantation (ASCT) are often not tolerated by elderly patients, on one hand. Single high-dose melphalan, on the other hand, has been shown to be safe and active as a pretransplant preparativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27132eaf47bbdc429cdeb519794f1b61
https://doi.org/10.1002/hon.2348
https://doi.org/10.1002/hon.2348
Autor:
Ulrich Mey, Adrian Schmidt, K. Eckhardt, Felicitas Hitz, Thomas Pabst, Simona Berardi Vilei, Clemens B. Caspar, Panagiotis Samaras, Fatime Krasniqi, Christian Rothermundt, Milica Enoiu, Emanuele Zucca, Nicolas Mach, Anne Cairoli, Natalie Fischer, Stephanie Rondeau
Publikováno v:
British Journal of Haematology. 174:255-263
An increasing number of older patients are suffering from aggressive lymphoma. Effective and more tolerable treatment regimens are urgently needed for this growing patient population. Patients with aggressive lymphoma not eligible for anthracycline-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76766b8123aef7aac72cb2bf0db59106
https://doi.org/10.1111/bjh.14049
https://doi.org/10.1111/bjh.14049
Autor:
U Hasler-Strub, Patrick Neven, Khalil Zaman, Christoph Mamot, Hanne Hawle, Christine Biaggi Rudolf, Christoph Rochlitz, Hans Wiliders, Ralph Winterhalder, Andreas Mueller, Catherine Berset, Lucien Perey, Stephanie Rondeau
Publikováno v:
European Journal of Cancer. 51:1212-1220
Background Second line endocrine therapy has limited antitumour activity. Fulvestrant inhibits and downregulates the oestrogen receptor. The mitogen-activated protein kinase (MAPK) pathway is one of the major cascades involved in resistance to endocr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3243150cbfb7657dfecf2c53539af63d
https://doi.org/10.1016/j.ejca.2015.03.016
https://doi.org/10.1016/j.ejca.2015.03.016
Autor:
Thomas Pabst, Felicitas Hitz, Karin Ribi, Anastasios Stathis, Natalie Fischer, Ulrich Mey, Stephanie Rondeau, Kerri M. Clough-Gorr, Milica Enoiu
Publikováno v:
Ribi, Karin; Rondeau, Stéphanie; Hitz, Felicitas; Mey, Ulrich; Enoiu, Milica; Pabst, Thomas; Stathis, Anastasios; Fischer, Natalie; Clough-Gorr, Kerri M (2017). Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma. Supportive care in cancer, 25(9), pp. 2833-2842. Springer 10.1007/s00520-017-3698-4
PURPOSE To evaluate the efficacy and tolerability of chemotherapy, a geriatric assessment is recommended in elderly patients with cancer. We aimed to characterize and compare patients with aggressive lymphoma by objective response and survival status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::831ea0d9d47d89ac89010053a9f564f7
Autor:
Sergio Cogliatti, Chern Siang Lee, Margaret Ashton-Key, Stephanie Rondeau, Shu-Fang Hsu Schmitz, Peter Johnson, Mark S. Cragg, Michele Ghielmini
Publikováno v:
British Journal of Haematology. 168:145-148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0567aa1181572e56804a85b611402410
https://doi.org/10.1111/bjh.13071
https://doi.org/10.1111/bjh.13071
Autor:
Ralph Winterhalder, Lucien Perey, Catherine Berset, C Biaggi Rudolf, Christoph Mamot, Patrick Neven, Stephanie Rondeau, Andreas Mueller, H Wiliders, Christoph Rochlitz, U Hasler-Strub, Khalil Zaman
Publikováno v:
Cancer Research. 73:P2-16
Background: Mitogen-activated protein kinase (MAPK) pathway is one of the major signaling cascades responsible for resistance to endocrine therapy by promoting estrogen-independent tumor growth. Sel is a potent selective MEK1 and MEK2 inhibitor activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95d34ff1a732e9cfe1a6c1389067516d
https://doi.org/10.1158/0008-5472.sabcs13-p2-16-19
https://doi.org/10.1158/0008-5472.sabcs13-p2-16-19
Autor:
Michèle, Voegeli, Stephanie, Rondeau, Simona, Berardi Vilei, Erika, Lerch, Luciano, Wannesson, Thomas, Pabst, Jochen, Rentschler, Mario, Bargetzi, Lorenz, Jost, Nicolas, Ketterer, Angelika, Bischof Delaloye, Michele, Ghielmini
Publikováno v:
Hematological oncology. 35(4)
Standard conditioning regimens for autologous stem cell transplantation (ASCT) are often not tolerated by elderly patients, on one hand. Single high-dose melphalan, on the other hand, has been shown to be safe and active as a pretransplant preparativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::048c3aa66f42f64a9c13026faf388de0
https://pubmed.ncbi.nlm.nih.gov/27677906
https://pubmed.ncbi.nlm.nih.gov/27677906
Autor:
Michele Ghielmini, Auro Del Giglio, Christine Biaggi Rudolf, Thomas Pabst, Christian Taverna, Andreas Lohri, Ingmar A.F.M. Heijnen, Daniel A. Vorobiof, Giovanni Martinelli, Emanuele Zucca, Daniele Laszlo, Daniel Rauch, Walter Mingrone, Felicitas Hitz, Johann Raats, Lidija Cevreska, Anna Vanazzi, Stephanie Rondeau, Corinne Rusterholz
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(5)
Purpose Rituximab maintenance therapy has been shown to improve progression-free survival in patients with follicular lymphoma; however, the optimal duration of maintenance treatment remains unknown. Patients and Methods Two hundred seventy patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04a61b3c6a4b811c3fc17b3428190417
https://pubmed.ncbi.nlm.nih.gov/26712227
https://pubmed.ncbi.nlm.nih.gov/26712227